In this regard, a recent study indicates TMPO-AS1 as a novel oncogene in HCC, where it competitively binds to miR-126-3p, thus increasing LRP6 expression to activate the Wnt/β-catenin pathway [116]. The gene discussed is TMPO; the disease is hepatocellular carcinoma.